EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Document 62012TA0493

Case T-493/12: Judgment of the General Court of 24 September 2014  — Sanofi v OHIM — GP Pharm (GEPRAL) (Community trade mark — Opposition proceedings — International registration designating the European Community — Word mark GEPRAL — Earlier international word mark DELPRAL — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009)

OJ C 388, 3.11.2014, p. 12–13 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

3.11.2014   

EN

Official Journal of the European Union

C 388/12


Judgment of the General Court of 24 September 2014 — Sanofi v OHIM — GP Pharm (GEPRAL)

(Case T-493/12) (1)

((Community trade mark - Opposition proceedings - International registration designating the European Community - Word mark GEPRAL - Earlier international word mark DELPRAL - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009))

2014/C 388/14

Language of the case: English

Parties

Applicant: Sanofi SA (Paris, France) (represented by: C. Hertz-Eichenrode, lawyer)

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: P. Geroulakos, acting as Agent)

Other party to the proceedings before the Board of Appeal of OHIM: GP Pharm SA (Sant Quinti de Mediona, Spain)

Re:

Action brought against the decision of the Second Board of Appeal of OHIM of 5 September 2012 (Case R 201/2012-2), concerning opposition proceedings between Sanofi SA and GP Pharm SA.

Operative part of the judgment

The Court:

1.

Annuls the Decision of the Second Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM) of 5 September 2012 (Case R 201/2012-2), concerning opposition proceedings between Sanofi SA and GP Pharm SA;

2.

Orders OHIM to pay the costs.


(1)  OJ C 26, 26.1.2013.


Top